Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meetings, 55231-55232 [2019-22378]
Download as PDF
<![CDATA[
55231
Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices
official who may be contacted for
additional information is Fred
Pietrangeli, Director for Office of Debt
Management (202) 622–1876.
FOR FURTHER INFORMATION CONTACT:
Copies of the submissions may be
obtained from Spencer W. Clark by
emailing PRA@treasury.gov, calling
(202) 927–5331, or viewing the entire
information collection request at
www.reginfo.gov.
SUPPLEMENTARY INFORMATION:
Dated: October 4, 2019.
Fred Pietrangeli,
Director for Office of Debt Management.
[FR Doc. 2019–22121 Filed 10–11–19; 8:45 am]
BILLING CODE 4810–25–M
DEPARTMENT OF THE TREASURY
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; CDFI
Program and NACA Program
Application
Departmental Offices, U.S.
Department of the Treasury.
AGENCY:
ACTION:
Notice.
The Department of the
Treasury will submit the following
information collection requests to the
Office of Management and Budget
(OMB) for review and clearance in
accordance with the Paperwork
Reduction Act of 1995, on or after the
date of publication of this notice. The
public is invited to submit comments on
these requests.
SUMMARY:
Comments should be received on
or before November 14, 2019 to be
assured of consideration.
DATES:
Send comments regarding
the burden estimate, or any other aspect
of the information collection, including
suggestions for reducing the burden, to
(1) Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attention: Desk Officer for
Treasury, New Executive Office
Building, Room 10235, Washington, DC
20503, or email at OIRA_Submission@
OMB.EOP.gov and (2) Treasury PRA
Clearance Officer, 1750 Pennsylvania
Ave. NW, Suite 8100, Washington, DC
20220, or email at PRA@treasury.gov.
ADDRESSES:
Community Development Financial
Institutions Fund (CDFIF)
Title: CDFI Program and NACA
Program Application.
OMB Control Number: 1559–0021.
Type of Review: Revision of a
currently approved collection.
Description: Pursuant to the Riegle
Community Development Banking and
Financial Institutions Act of 1994, as
amended (the Act, 12 U.S.C. 4701 et
seq.), the Community Development
Financial Institutions (CDFI) Program
provides financial and technical
assistance to selected applicants and
Community Development Financial
Institutions (CDFIs) in order to enhance
their ability to make loans and
investments and provide services for the
benefit of designated Investment Areas
and Targeted Populations.
The application questions for the
CDFI Fund’s Financial Assistance (FA)
and Technical Assistance (TA) programs
have been modified to reflect public
comments received through the request
for public comment as required the
Paperwork Reduction Act (PRA). The
revised FA application includes the
Base-FA application as well as the
following applications for awards that
are provided as supplemental to the
Base-FA award: Persistent Poverty
County Financial Assistance (PPC–FA),
Healthy Food Financing InitiativeFinancial Assistance (HFFI–FA), and
Disability Funds-Financial Assistance
(DF–FA). The supplemental
applications are only completed if the
applicant is requesting those specific
funds.
The information collected will be
used to select awardees, based on a
merit-based selection process. The
requested information is required by the
CDFI Program regulations (12 CFR part
1805) and respective Notice of Funds
Availabilities.
Form: None.
Affected Public: Businesses or other
for-profits, Not-for-profit institutions.
Estimated Number of Respondents:
500.
Frequency of Response: On occasion.
Estimated Total Number of Annual
Responses: 500.
Estimated Time per Response: 100
hours.
Estimated Total Annual Burden
Hours: 50,000.
Authority: 44 U.S.C. 3501 et seq.
Dated: October 8, 2019.
Spencer W. Clark,
Treasury PRA Clearance Officer.
[FR Doc. 2019–22379 Filed 10–11–19; 8:45 am]
BILLING CODE 4810–70–P
DEPARTMENT OF VETERANS
AFFAIRS
Joint Biomedical Laboratory Research
and Development and Clinical Science
Research and Development Services
Scientific Merit Review Board, Notice
of Meetings
The Department of Veterans Affairs
(VA) gives notice under Federal
Advisory Committee Act that the
subcommittees of the Joint Biomedical
Laboratory Research and Development
and Clinical Science Research and
Development Services Scientific Merit
Review Board (JBL/CS SMRB) will be
held on the dates below from 8:00 a.m.
to 5:00 p.m. (unless otherwise listed) at
the 20 F Conference Center, 20 F Street
NW, Washington, DC 20001 and at the
Office of Research and Development,
1100 First Street NE, Washington, DC
20002:
khammond on DSKJM1Z7X2PROD with NOTICES
Meeting
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
Date(s)
Surgery Subcommittee ...............................................................................................................................
Pulmonary Medicine Subcommittee ...........................................................................................................
Infectious Diseases-B Subcommittee ........................................................................................................
Oncology-A/D Subcommittee .....................................................................................................................
Hematology Subcommittee ........................................................................................................................
Oncology-C Subcommittee ........................................................................................................................
Cellular & Molecular Medicine Subcommittee ...........................................................................................
Oncology-B/E Subcommittee .....................................................................................................................
Immunology & Dermatology-A Subcommittee ...........................................................................................
Mental Health & Behavioral Sciences-C Subcommittee ............................................................................
Cardiovascular Studies-A Subcommittee ...................................................................................................
Endocrinology-A Subcommittee .................................................................................................................
Mental Health & Behavioral Sciences-P ....................................................................................................
Neurobiology-C Subcommittee ..................................................................................................................
Neurobiology-E Subcommittee ...................................................................................................................
VerDate Sep<11>2014
16:25 Oct 11, 2019
Jkt 250001
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
E:\FR\FM\15OCN1.SGM
15OCN1
November
November
November
November
November
November
November
November
November
November
November
November
November
November
November
12,
13,
14,
14,
15,
15,
18,
18,
20,
20,
21,
21,
21,
21,
22,
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
2019.
55232
Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices
Meeting
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
BL/CS
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
R&D
Endocrinology-B Subcommittee .................................................................................................................
Mental Health & Behavioral Sciences-A Subcommittee ............................................................................
Nephrology Subcommittee .........................................................................................................................
Neurobiology-B Subcommittee ...................................................................................................................
Infectious Diseases-A Subcommittee ........................................................................................................
Neurobiology-F Subcommittee ...................................................................................................................
Cardiovascular Studies-B Subcommittee ...................................................................................................
Gastroenterology Subcommittee ................................................................................................................
Neurobiology-P Subcommittee ...................................................................................................................
Neurobiology-A Subcommittee ...................................................................................................................
Neurobiology-D Subcommittee ..................................................................................................................
Gulf War Research Subcommittee ............................................................................................................
Eligibility Subcommittee .............................................................................................................................
The purpose of the subcommittees is
to provide advice on the scientific
quality, budget, safety and mission
relevance of investigator-initiated
research proposals submitted for VA
merit review evaluation. Proposals
submitted for review include various
medical specialties within the general
areas of biomedical, behavioral and
clinical science research.
These subcommittee meetings will be
closed to the public for the review,
discussion, and evaluation of initial and
renewal research proposals, which
involve reference to staff and consultant
critiques of research proposals.
Discussions will deal with scientific
merit of each proposal and
qualifications of personnel conducting
the studies, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Additionally, premature disclosure of
research information could significantly
obstruct implementation of proposed
agency action regarding the research
proposals. As provided by subsection
10(d) of Public Law 92–463, as amended
by Public Law 94–409, closing the
subcommittee meetings is in accordance
with Title 5 U.S.C. 552b(c)(6) and (9)(B).
Those who would like to obtain a
copy of the minutes from the closed
subcommittee meetings and rosters of
the subcommittee members should
contact Holly Krull, Ph.D., Manager,
Merit Review Program (10X2B),
Department of Veterans Affairs, 810
Vermont Avenue NW, Washington, DC
20420, at (202) 632–8522 or email at
holly.krull@va.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
Date(s)
VerDate Sep<11>2014
16:25 Oct 11, 2019
Jkt 250001
Dated: October 8, 2019.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2019–22378 Filed 10–11–19; 8:45 am]
BILLING CODE 8320–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Creating Options for Veterans
Expedited Recovery (COVER)
Commission, Notice of Meeting
In accordance with the Federal
Advisory Committee Act, the Creating
Options for Veterans Expedited
Recovery (COVER) Commission gives
notice of a meeting to be held on
October 24 and 25, 2019, at the VHA
National Conference Center, 2011
Crystal Drive, Crystal City, Virginia
22202. The public session on October 24
will begin at 1:00 p.m. and conclude at
approximately 5:00 p.m. On October 25,
the public session will begin at 8:30
a.m. and conclude at approximately
12:00 p.m. (all times Eastern).
The purpose of the COVER
Commission is to examine the evidencebased therapy treatment model used by
the Department of Veterans Affairs (VA)
for treating mental health conditions of
Veterans and the potential benefits of
incorporating complementary and
integrative health approaches as
standard practice throughout the
Department.
Members of the public are invited to
attend open sessions in-person or via
PO 00000
Frm 00099
Fmt 4703
Sfmt 9990
November 25, 2019.
December 3, 2019.
December 3, 2019.
December 3, 2019.
December 4, 2019.
December 4, 2019.
December 5, 2019.
December 5, 2019.
December 5, 2019.
December 6, 2019.
December 6, 2019.
December 6, 2019.
January 17, 2020.
telephone listening line. Only a limited
amount of seating will be available, and
members of the public will be seated on
a first come-first served basis. The
listening line number for October 24 is
844–376–0278 access code 771669984#.
The listening line number for October
25 is 844–376–0278 access code
623057095#. Listening lines will be
activated approximately 10 minutes
prior to each day’s sessions. Members of
the public utilizing the listening line are
asked to confirm their attendance via an
email to COVERCommission@va.gov.
The videotaping or recording of
Commission proceedings is discouraged
as it may be disruptive to the
Commission’s work.
Any member of the public seeking
additional information including copies
of materials referenced during open
sessions should email the Designated
Federal Officer for the Commission, Mr.
John Goodrich, at COVERCommission@
va.gov. Although there will not be time
allotted for members of the public to
speak, the COVER Commission will
accept written comments which may be
sent to the email address noted. In
communications with the Commission,
the writers must identify themselves
and state the organizations, associations,
or persons they represent.
Dated: October 8, 2019.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2019–22373 Filed 10–11–19; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 84, Number 199 (Tuesday, October 15, 2019)]
[Notices]
[Pages 55231-55232]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22378]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Joint Biomedical Laboratory Research and Development and Clinical
Science Research and Development Services Scientific Merit Review
Board, Notice of Meetings
The Department of Veterans Affairs (VA) gives notice under Federal
Advisory Committee Act that the subcommittees of the Joint Biomedical
Laboratory Research and Development and Clinical Science Research and
Development Services Scientific Merit Review Board (JBL/CS SMRB) will
be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless
otherwise listed) at the 20 F Conference Center, 20 F Street NW,
Washington, DC 20001 and at the Office of Research and Development,
1100 First Street NE, Washington, DC 20002:
----------------------------------------------------------------------------------------------------------------
Meeting Date(s)
----------------------------------------------------------------------------------------------------------------
BL/CS R&D Surgery Subcommittee............................. November 12, 2019.
BL/CS R&D Pulmonary Medicine Subcommittee.................. November 13, 2019.
BL/CS R&D Infectious Diseases-B Subcommittee............... November 14, 2019.
BL/CS R&D Oncology-A/D Subcommittee........................ November 14, 2019.
BL/CS R&D Hematology Subcommittee.......................... November 15, 2019.
BL/CS R&D Oncology-C Subcommittee.......................... November 15, 2019.
BL/CS R&D Cellular & Molecular Medicine Subcommittee....... November 18, 2019.
BL/CS R&D Oncology-B/E Subcommittee........................ November 18, 2019.
BL/CS R&D Immunology & Dermatology-A Subcommittee.......... November 20, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-C November 20, 2019.
Subcommittee.
BL/CS R&D Cardiovascular Studies-A Subcommittee............ November 21, 2019.
BL/CS R&D Endocrinology-A Subcommittee..................... November 21, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-P............ November 21, 2019.
BL/CS R&D Neurobiology-C Subcommittee...................... November 21, 2019.
BL/CS R&D Neurobiology-E Subcommittee...................... November 22, 2019.
[[Page 55232]]
BL/CS R&D Endocrinology-B Subcommittee..................... November 25, 2019.
BL/CS R&D Mental Health & Behavioral Sciences-A December 3, 2019.
Subcommittee.
BL/CS R&D Nephrology Subcommittee.......................... December 3, 2019.
BL/CS R&D Neurobiology-B Subcommittee...................... December 3, 2019.
BL/CS R&D Infectious Diseases-A Subcommittee............... December 4, 2019.
BL/CS R&D Neurobiology-F Subcommittee...................... December 4, 2019.
BL/CS R&D Cardiovascular Studies-B Subcommittee............ December 5, 2019.
BL/CS R&D Gastroenterology Subcommittee.................... December 5, 2019.
BL/CS R&D Neurobiology-P Subcommittee...................... December 5, 2019.
BL/CS R&D Neurobiology-A Subcommittee...................... December 6, 2019.
BL/CS R&D Neurobiology-D Subcommittee...................... December 6, 2019.
BL/CS R&D Gulf War Research Subcommittee................... December 6, 2019.
BL/CS R&D Eligibility Subcommittee......................... January 17, 2020.
----------------------------------------------------------------------------------------------------------------
The purpose of the subcommittees is to provide advice on the
scientific quality, budget, safety and mission relevance of
investigator-initiated research proposals submitted for VA merit review
evaluation. Proposals submitted for review include various medical
specialties within the general areas of biomedical, behavioral and
clinical science research.
These subcommittee meetings will be closed to the public for the
review, discussion, and evaluation of initial and renewal research
proposals, which involve reference to staff and consultant critiques of
research proposals. Discussions will deal with scientific merit of each
proposal and qualifications of personnel conducting the studies, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy. Additionally, premature disclosure of research
information could significantly obstruct implementation of proposed
agency action regarding the research proposals. As provided by
subsection 10(d) of Public Law 92-463, as amended by Public Law 94-409,
closing the subcommittee meetings is in accordance with Title 5 U.S.C.
552b(c)(6) and (9)(B).
Those who would like to obtain a copy of the minutes from the
closed subcommittee meetings and rosters of the subcommittee members
should contact Holly Krull, Ph.D., Manager, Merit Review Program
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW,
Washington, DC 20420, at (202) 632-8522 or email at [email protected].
Dated: October 8, 2019.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-22378 Filed 10-11-19; 8:45 am]
BILLING CODE 8320-01-P
